We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead Sciences announced yesterday that it has filed a new drug application (NDA) with the FDA, seeking approval for remdesivir for the treatment of COVID-19 patients. Read More
The FDA has approved GlaxoSmithKline’s Blenrep (belantamab mafodotin-blmf) for the treatment of adults with elapsed or refractory multiple myeloma who have received at least four prior therapies. Read More